The Ca²⁺-Activated K⁺ Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy

• Yi-Je Chen,

  Affiliation Department of Pharmacology, University of California, Davis, California, United States of America

  ⨯
• Jenny Lam,

  Affiliation Department of Pharmacology, University of California, Davis, California, United States of America

  ⨯
• Clare R. Gregory,

  Affiliation Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California, United States of America

  ⨯
• Sonja Schrepfer,

  Affiliations University Heart Center Hamburg, Transplant and Stem Cell Immunobiology Lab, Hamburg, Germany, Department of Cardiothoracic Surgery Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• Heike Wulff

  * E-mail: hwulff@ucdavis.edu

  Affiliation Department of Pharmacology, University of California, Davis, California, United States of America

  ⨯